Cargando…

Functional Impairments Associated With ADHD in Adulthood and the Impact of Pharmacological Treatment

OBJECTIVE: Among untreated adults, functional impairments associated with ADHD are widespread and cumulative, and can include social, educational, and professional impairments, increased risk of accidents and mortality, and reduced quality of life. Here, we review the most prominent functional impai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosheleff, Alisa R., Mason, Oren, Jain, Rakesh, Koch, Jennifer, Rubin, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173356/ https://www.ncbi.nlm.nih.gov/pubmed/36876491 http://dx.doi.org/10.1177/10870547231158572

Ejemplares similares

“Late-onset” ADHD symptoms in young adulthood: is this ADHD?
por: Riglin, Lucy, et al.
Publicado: (2022)

Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence
por: McCarthy, Suzanne, et al.
Publicado: (2012)

The Etiological Structure of Cognitive-Neurophysiological Impairments in ADHD in Adolescence and Young Adulthood
por: Michelini, Giorgia, et al.
Publicado: (2018)

ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications
por: Salvi, Virginio, et al.
Publicado: (2021)

Five‐year outcomes of ADHD diagnosed in adulthood
por: Nylander, Elin, et al.
Publicado: (2020)

Empirical examination of executive functioning, ADHD associated behaviors, and functional impairments in adults with persistent ADHD, remittent ADHD, and without ADHD
por: Roselló, Belén, et al.
Publicado: (2020)

Attention-Deficit/Hyperactivity Disorder (ADHD) in Adulthood: Concordance and Differences between Self- and Informant Perspectives on Symptoms and Functional Impairment
por: Mörstedt, Beatrice, et al.
Publicado: (2015)

Pharmacological approaches of ADHD
por: Cooper, R., et al.
Publicado: (2021)

Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Nasser, Azmi, et al.
Publicado: (2021)

ADHD, financial distress, and suicide in adulthood: A population study
por: Beauchaine, Theodore P., et al.
Publicado: (2020)

Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended‐release in children and adolescents with attention‐deficit/hyperactivity disorder
por: Nasser, Azmi, et al.
Publicado: (2021)

ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine
por: Krause, Johanna, et al.
Publicado: (2006)

Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood
por: Riglin, Lucy, et al.
Publicado: (2021)

Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment
por: Mowlem, Florence D., et al.
Publicado: (2018)

Investigating routine care non-pharmacological treatment for adolescents with ADHD
por: Sibley, Margaret H., et al.
Publicado: (2022)

Functional Brain Connectivity Differences Between Different ADHD Presentations: Impaired Functional Segregation in ADHD-Combined Presentation but not in ADHD-Inattentive Presentation
por: Ghaderi, Amir Hossein, et al.
Publicado: (2017)

The Etiological and Predictive Association Between ADHD and Cognitive Performance From Childhood to Young Adulthood
por: Vainieri, Isabella, et al.
Publicado: (2023)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009)

Pharmacological interventions for ADHD: how do adolescent and adult patient beliefs and attitudes impact treatment adherence?
por: McCarthy, Suzanne
Publicado: (2014)

Pharmacological and therapeutic directions in ADHD: Specificity in the PFC
por: Levy, Florence
Publicado: (2008)

Aging-Dependent Genetic Effects Associated to ADHD Predict Longitudinal Changes of Ventricular Volumes in Adulthood
por: Vilor-Tejedor, Natalia, et al.
Publicado: (2020)

Gray matter networks associated with attention and working memory deficit in ADHD across adolescence and adulthood
por: Duan, Kuaikuai, et al.
Publicado: (2021)

Childhood ADHD and Risk for Substance Dependence in Adulthood: A Longitudinal, Population-Based Study
por: Levy, Sharon, et al.
Publicado: (2014)

Clinical implications of ADHD, ASD, and their co-occurrence in early adulthood—the prospective ABIS-study
por: Lebeña, Andrea, et al.
Publicado: (2023)

Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (Qelbree(TM)) in Healthy Adult Subjects
por: Wang, Zhao, et al.
Publicado: (2021)

Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial
por: Haugan, Anne-Lise Juul, et al.
Publicado: (2022)

Once-daily medications for the pharmacological management of ADHD in adults
por: Tcheremissine, Oleg V, et al.
Publicado: (2009)

The Impact of Depressive Symptoms in Adults with ADHD Symptoms on Family Function and ADHD Symptoms of Their Children
por: Hong, Soon-Beom, et al.
Publicado: (2014)

Fetal exposure to dichloroacetic acid and impaired cognitive function in the adulthood
por: Wang, Yue, et al.
Publicado: (2020)

The effect of autistic traits on response to and side-effects of pharmacological ADHD treatment in children with ADHD: results from a prospective clinical cohort
por: Lilja, Maria M., et al.
Publicado: (2022)

Is a Virtual Reality Test Able to Predict Current and Retrospective ADHD Symptoms in Adulthood and Adolescence?
por: Areces, Débora, et al.
Publicado: (2019)

Individual trajectories of asthma, obesity and ADHD during the transition from childhood and adolescence to young adulthood
por: Krause, Laura, et al.
Publicado: (2021)

The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials
por: Nasser, Azmi, et al.
Publicado: (2021)

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder
por: Nasser, Azmi, et al.
Publicado: (2022)

Exploring ADHD Symptoms and Associated Impairment Across Development
por: Niina, Ayako, et al.
Publicado: (2022)

Non-pharmacological approaches for treating children with ADHD inattentive type
por: Langberg, Joshua M, et al.
Publicado: (2009)

The Impact of Internalizing Symptoms on Impairment for Children With ADHD: A Strength-Based Perspective
por: Bethune, Sarah C., et al.
Publicado: (2022)

Associated predictors of functional impairment among adolescents with ADHD—a cross-sectional study
por: Meyer, Jenny, et al.
Publicado: (2022)

Functional impairments in ADHD in function of anxiety, depressive and somatic complains in Brazilian young adults
por: Carreiro, L.R., et al.
Publicado: (2021)

3Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD
por: Young, Susan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_v0qmsekcsgmtjp64klojsdi5pb